Combination therapy for the treatment of diabetes and related conditions

Finton Sirockin, Nils Ostermann, Jonathan Mark Sutton, Christopher Antony Hurley, Amanda Fillmore, Christopher Higgs, Neil Victor Harris, David Edward Clark, Robert Edward Mackenzie, Garry Fenton, Stephen John Dunsdon, Daniel Kaspar Baeschlin, Sussie Lerche Krintel, Condensed heterocyclic compounds useful as dpp-iv inhibitors ,(2006)

Bruce David Plymouth Roth, (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof ,(1990)

John W. Benbow, Yu Hui, David W. Piotrowski, Substituted 3-amino-pyrrolidino-4-lactams ,(2007)

Matthias Eckhardt, Frank Himmelsbach, Michael Mark, New 8-substituted-xanthine derivatives, useful e.g. for treating diabetes and arthritis, act by inhibiting dipeptidylpeptidase-IV ,(2001)

Klaus Dugi, Frank Himmelsbach, Michael Mark, Uses of DPP-IV inhibitors ,(2007)

Anila Chadha, Malcolm S Schwartz, Type 2 diabetes mellitus in childhood: obesity and insulin resistance. The Journal of the American Osteopathic Association. ,vol. 108, pp. 518- 524 ,(2008) , 10.7556/JAOA.2008.108.9.518

Elke Langkopf, Ralf R. H. Lotz, Matthias Eckhardt, Frank Himmelsbach, Michael Mark, Roland Maier, Xanthine derivates, their preparation and their use in pharmaceutical compositions ,(2009)

Kyle A. Fliszar, Laman Alani, Soumojeet Ghosh, Ashkan Kamali, Monica Tijerina, Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin ,(2006)

Tesfaye Biftu, Ann E. Weber, Xiaoxia Qian, Gui-Bai Liang, Danqing Dennis Feng, Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes ,(2003)

David J. Augeri, David A. Betebenner, David R. Magnin, Lawrence G. Hamann, Jeffrey A. Robl, Richard B. Sulsky, Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method ,(2001)